Cytochrome P450 3As gene expression and testosterone 6 beta-hydroxylase activity in human fetal membranes and placenta at full term

Biological & Pharmaceutical Bulletin
Kayoko MaezawaShigeru Ohmori

Abstract

Expression levels of cytochrome P450 (CYP) 3A4, CYP3A5 and CYP3A7 mRNAs in placentas and fetal membranes, which were split into amnion and chorion leave attached decidua (chorion/decidua), obtained from pregnant women with normal delivery (5 subjects) and Caesarean section (15 subjects) were determined. These CYP3A mRNAs were also expressed in amnion and chorion/decidua together with placenta, although the expression level of these mRNAs was strikingly different between subjects. The expression level of the CYP3A4 mRNA in the placenta was about 2-fold higher than those in amnion and chorion/decidua. On the other hand, the expression levels of CYP3A5 and CYP3A7 mRNAs were highest in chorion/decidua. The immunologically related protein(s) with CYP3A7 was detected in all tissues examined. Testosterone 6beta-hydroxylase activity in homogenate of human placenta, amnion and chorion/decidua were 26.6, 3.7 and 4.6 pmol/h/mg protein, respectively. These results suggest that CYP3As in fetal membranes have the metabolic function to protect the fetus from exposure to drugs.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Oct 1, 1991·Archives of Biochemistry and Biophysics·D J WaxmanK Korzekwa
Mar 1, 1997·Epilepsia·P PienimäkiK Vähäkangas
Jun 1, 1997·Toxicology and Applied Pharmacology·A RasheedD G McCarver-May
Feb 9, 2000·Pharmacology & Therapeutics·J A RingD J Morgan
Jun 6, 2000·Advanced Drug Delivery Reviews·M Pasanen
Aug 3, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·V MeunierG Fabre
Feb 13, 2001·Biochemical and Biophysical Research Communications·G BertilssonP Blomquist
Apr 12, 2001·The Journal of Biological Chemistry·A GeickO Burk
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Jun 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gang LuoLiang-Shang Gan
Mar 19, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ajay MadanAndrew Parkinson
May 30, 2003·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Masuhiro NishimuraTetsuo Satoh
Sep 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Jeffrey C StevensMatthew J Zaya
Jun 2, 2004·Clinical Pharmacokinetics·Michael R SymeJeffrey A Keelan
Oct 15, 2005·Nature Reviews. Drug Discovery·Larry C Wienkers, Timothy G Heath
Feb 20, 2007·Current Drug Metabolism·Celia P Martínez-JiménezM José Gómez-Lechón
Jun 2, 2007·Expert Opinion on Drug Metabolism & Toxicology·Päivi MyllynenKirsi Vähäkangas
Sep 11, 2007·Drug Metabolism and Pharmacokinetics·Koki KojimaYasushi Yamazoe

❮ Previous
Next ❯

Citations

Sep 28, 2017·Fetal and Pediatric Pathology·Sara K QuinneyAvinash S Patil
Jan 21, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xia LiHui Wang
Sep 28, 2018·Frontiers in Pharmacology·Waranya ChatuphonprasertIsabella Ellinger
Mar 5, 2020·Expert Review of Clinical Pharmacology·Ricardo Blanco-CastañedaMartha Sosa-Macías
Oct 20, 2021·British Journal of Clinical Pharmacology·Grazielle de Fátima Pinto RodriguesAlessandra Cristina Marcolin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.